STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular protein-protein interactions of the STING Pathway; a major driver of innate immunity, and regulator of tumorigenesis and autoimmune disorders. The company has identified and validated compoundsthat sensitizes the STING pathway and by this modulates the tumor microenvironment to support a potent anti-tumoral response.

Biotechnology

Health Care

Pharmaceutical

Therapeutics

Stipe Therapeutics

Claus Olesen

Ulrich Sensfuss

Justin Joseph

isis BENOIT-LIZON

Esben Axelgaard

Richard Bethell

Stipe Therapeutics

Org chart

Similar companies